Year | Should receive full-dose DOAC | Received Low-Dose DOAC | Â | Should receive full-dose Dabi | Received Low-Dose Dabi | Â | Should receive full-dose Riva | Received Low-Dose Riva | Â | Should receive full-dose Apix | Received Low-Dose Apix | Â |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2010 | 9 | 2 | 22% | 9 | 2 | 22% | Â | Â | Â | Â | Â | Â |
2011 | 1635 | 37 | 2% | 1635 | 37 | 2% | Â | Â | Â | Â | Â | Â |
2012 | 2860 | 79 | 3% | 2814 | 76 | 3% | 46 | 3 | 7% | Â | Â | Â |
2013 | 3958 | 158 | 4% | 3383 | 92 | 3% | 507 | 50 | 10% | 68 | 16 | 24% |
2014 | 9791 | 626 | 6% | 5431 | 104 | 2% | 2904 | 289 | 10% | 1456 | 233 | 16% |
2015 | 18,345 | 1206 | 7% | 5530 | 73 | 1% | 5424 | 389 | 7% | 7391 | 744 | 10% |
2016 | 31,327 | 1971 | 6% | 7344 | 98 | 1% | 7946 | 490 | 6% | 16,037 | 1383 | 9% |